Selected research
Market Analysis & Forecast
Global Immunity Nutraceutical Ingredient Market Analysis and Forecast 2026-2032
Market perspective
The global Immunity Nutraceutical Ingredient market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Immunity Nutraceutical Ingredient is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Immunity Nutraceutical Ingredient is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Immunity Nutraceutical Ingredient is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Immunity Nutraceutical Ingredient is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Immunity Nutraceutical Ingredient include Tate & Lyle PLC (U.K), Koninklijke DSM N.V. (Netherlands), Ingredion Incorporated (U.S), Arla Foods (Denmark) and Ajinomoto Co., Inc. (Japan), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Immunity Nutraceutical Ingredient, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Immunity Nutraceutical Ingredient, also provides the sales of main regions and countries. Of the upcoming market potential for Immunity Nutraceutical Ingredient, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immunity Nutraceutical Ingredient sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Immunity Nutraceutical Ingredient market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Immunity Nutraceutical Ingredient sales, projected growth trends, production technology, application and end-user industry.
Immunity Nutraceutical Ingredient Segment by Company
Tate & Lyle PLC (U.K)
Koninklijke DSM N.V. (Netherlands)
Ingredion Incorporated (U.S)
Arla Foods (Denmark)
Ajinomoto Co., Inc. (Japan)
Immunity Nutraceutical Ingredient Segment by Type
Carotenoids
Minerals
Omega-3 fatty acids
Fibers & specialty carbohydrates
Phytochemical and plant extracts
Others
Immunity Nutraceutical Ingredient Segment by Application
Dietary supplements
Functional beverages
Functional food
Personal care
Animal nutrition
Immunity Nutraceutical Ingredient Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunity Nutraceutical Ingredient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunity Nutraceutical Ingredient and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunity Nutraceutical Ingredient.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Immunity Nutraceutical Ingredient in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Immunity Nutraceutical Ingredient manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunity Nutraceutical Ingredient sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Carotenoids
- Minerals
- Omega-3 fatty acids
- Fibers & specialty carbohydrates
- Phytochemical and plant extracts
- Others
Applications
- Dietary supplements
- Functional beverages
- Functional food
- Personal care
- Animal nutrition
Companies covered
- Tate & Lyle PLC (U.K)
- Koninklijke DSM N.V. (Netherlands)
- Ingredion Incorporated (U.S)
- Arla Foods (Denmark)
- Ajinomoto Co., Inc. (Japan)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Immunity Nutraceutical Ingredient Market by Type
- 1.2.1 Global Immunity Nutraceutical Ingredient Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Carotenoids
- 1.2.3 Minerals
- 1.2.4 Omega-3 fatty acids
- 1.2.5 Fibers & specialty carbohydrates
- 1.2.6 Phytochemical and plant extracts
- 1.2.7 Others
- 1.3 Immunity Nutraceutical Ingredient Market by Application
- 1.3.1 Global Immunity Nutraceutical Ingredient Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Dietary supplements
- 1.3.3 Functional beverages
- 1.3.4 Functional food
- 1.3.5 Personal care
- 1.3.6 Animal nutrition
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Immunity Nutraceutical Ingredient Market Dynamics
- 2.1 Immunity Nutraceutical Ingredient Industry Trends
- 2.2 Immunity Nutraceutical Ingredient Industry Drivers
- 2.3 Immunity Nutraceutical Ingredient Industry Opportunities and Challenges
- 2.4 Immunity Nutraceutical Ingredient Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Immunity Nutraceutical Ingredient Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Immunity Nutraceutical Ingredient Revenue by Region
- 3.2.1 Global Immunity Nutraceutical Ingredient Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Immunity Nutraceutical Ingredient Revenue by Region (2021-2026)
- 3.2.3 Global Immunity Nutraceutical Ingredient Revenue by Region (2027-2032)
- 3.2.4 Global Immunity Nutraceutical Ingredient Revenue Market Share by Region (2021-2032)
- 3.3 Global Immunity Nutraceutical Ingredient Sales Estimates and Forecasts 2021-2032
- 3.4 Global Immunity Nutraceutical Ingredient Sales by Region
- 3.4.1 Global Immunity Nutraceutical Ingredient Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Immunity Nutraceutical Ingredient Sales by Region (2021-2026)
- 3.4.3 Global Immunity Nutraceutical Ingredient Sales by Region (2027-2032)
- 3.4.4 Global Immunity Nutraceutical Ingredient Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Immunity Nutraceutical Ingredient Revenue by Manufacturers
- 4.1.1 Global Immunity Nutraceutical Ingredient Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Immunity Nutraceutical Ingredient Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Immunity Nutraceutical Ingredient Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Immunity Nutraceutical Ingredient Sales by Manufacturers
- 4.2.1 Global Immunity Nutraceutical Ingredient Sales by Manufacturers (2021-2026)
- 4.2.2 Global Immunity Nutraceutical Ingredient Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Immunity Nutraceutical Ingredient Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Immunity Nutraceutical Ingredient Sales Price by Manufacturers (2021-2026)
- 4.4 Global Immunity Nutraceutical Ingredient Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Immunity Nutraceutical Ingredient Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Immunity Nutraceutical Ingredient Manufacturers, Product Type & Application
- 4.7 Global Immunity Nutraceutical Ingredient Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Immunity Nutraceutical Ingredient Market CR5 and HHI
- 4.8.2 2025 Immunity Nutraceutical Ingredient Tier 1, Tier 2, and Tier 3
5 Immunity Nutraceutical Ingredient Market by Type
- 5.1 Global Immunity Nutraceutical Ingredient Revenue by Type
- 5.1.1 Global Immunity Nutraceutical Ingredient Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Immunity Nutraceutical Ingredient Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Immunity Nutraceutical Ingredient Revenue Market Share by Type (2021-2032)
- 5.2 Global Immunity Nutraceutical Ingredient Sales by Type
- 5.2.1 Global Immunity Nutraceutical Ingredient Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Immunity Nutraceutical Ingredient Sales by Type (2021-2032) & (Tons)
- 5.2.3 Global Immunity Nutraceutical Ingredient Sales Market Share by Type (2021-2032)
- 5.3 Global Immunity Nutraceutical Ingredient Price by Type
6 Immunity Nutraceutical Ingredient Market by Application
- 6.1 Global Immunity Nutraceutical Ingredient Revenue by Application
- 6.1.1 Global Immunity Nutraceutical Ingredient Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Immunity Nutraceutical Ingredient Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Immunity Nutraceutical Ingredient Revenue Market Share by Application (2021-2032)
- 6.2 Global Immunity Nutraceutical Ingredient Sales by Application
- 6.2.1 Global Immunity Nutraceutical Ingredient Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Immunity Nutraceutical Ingredient Sales by Application (2021-2032) & (Tons)
- 6.2.3 Global Immunity Nutraceutical Ingredient Sales Market Share by Application (2021-2032)
- 6.3 Global Immunity Nutraceutical Ingredient Price by Application
7 Company Profiles
- 7.1 Tate & Lyle PLC (U.K)
- 7.1.1 Tate & Lyle PLC (U.K) Company Information
- 7.1.2 Tate & Lyle PLC (U.K) Business Overview
- 7.1.3 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Product Portfolio
- 7.1.5 Tate & Lyle PLC (U.K) Recent Developments
- 7.2 Koninklijke DSM N.V. (Netherlands)
- 7.2.1 Koninklijke DSM N.V. (Netherlands) Company Information
- 7.2.2 Koninklijke DSM N.V. (Netherlands) Business Overview
- 7.2.3 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Product Portfolio
- 7.2.5 Koninklijke DSM N.V. (Netherlands) Recent Developments
- 7.3 Ingredion Incorporated (U.S)
- 7.3.1 Ingredion Incorporated (U.S) Company Information
- 7.3.2 Ingredion Incorporated (U.S) Business Overview
- 7.3.3 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Product Portfolio
- 7.3.5 Ingredion Incorporated (U.S) Recent Developments
- 7.4 Arla Foods (Denmark)
- 7.4.1 Arla Foods (Denmark) Company Information
- 7.4.2 Arla Foods (Denmark) Business Overview
- 7.4.3 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Product Portfolio
- 7.4.5 Arla Foods (Denmark) Recent Developments
- 7.5 Ajinomoto Co., Inc. (Japan)
- 7.5.1 Ajinomoto Co., Inc. (Japan) Company Information
- 7.5.2 Ajinomoto Co., Inc. (Japan) Business Overview
- 7.5.3 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Product Portfolio
- 7.5.5 Ajinomoto Co., Inc. (Japan) Recent Developments
8 North America
- 8.1 North America Immunity Nutraceutical Ingredient Market Size by Type
- 8.1.1 North America Immunity Nutraceutical Ingredient Revenue by Type (2021-2032)
- 8.1.2 North America Immunity Nutraceutical Ingredient Sales by Type (2021-2032)
- 8.1.3 North America Immunity Nutraceutical Ingredient Price by Type (2021-2032)
- 8.2 North America Immunity Nutraceutical Ingredient Market Size by Application
- 8.2.1 North America Immunity Nutraceutical Ingredient Revenue by Application (2021-2032)
- 8.2.2 North America Immunity Nutraceutical Ingredient Sales by Application (2021-2032)
- 8.2.3 North America Immunity Nutraceutical Ingredient Price by Application (2021-2032)
- 8.3 North America Immunity Nutraceutical Ingredient Market Size by Country
- 8.3.1 North America Immunity Nutraceutical Ingredient Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Immunity Nutraceutical Ingredient Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Immunity Nutraceutical Ingredient Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Immunity Nutraceutical Ingredient Market Size by Type
- 9.1.1 Europe Immunity Nutraceutical Ingredient Revenue by Type (2021-2032)
- 9.1.2 Europe Immunity Nutraceutical Ingredient Sales by Type (2021-2032)
- 9.1.3 Europe Immunity Nutraceutical Ingredient Price by Type (2021-2032)
- 9.2 Europe Immunity Nutraceutical Ingredient Market Size by Application
- 9.2.1 Europe Immunity Nutraceutical Ingredient Revenue by Application (2021-2032)
- 9.2.2 Europe Immunity Nutraceutical Ingredient Sales by Application (2021-2032)
- 9.2.3 Europe Immunity Nutraceutical Ingredient Price by Application (2021-2032)
- 9.3 Europe Immunity Nutraceutical Ingredient Market Size by Country
- 9.3.1 Europe Immunity Nutraceutical Ingredient Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Immunity Nutraceutical Ingredient Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Immunity Nutraceutical Ingredient Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Immunity Nutraceutical Ingredient Market Size by Type
- 10.1.1 China Immunity Nutraceutical Ingredient Revenue by Type (2021-2032)
- 10.1.2 China Immunity Nutraceutical Ingredient Sales by Type (2021-2032)
- 10.1.3 China Immunity Nutraceutical Ingredient Price by Type (2021-2032)
- 10.2 China Immunity Nutraceutical Ingredient Market Size by Application
- 10.2.1 China Immunity Nutraceutical Ingredient Revenue by Application (2021-2032)
- 10.2.2 China Immunity Nutraceutical Ingredient Sales by Application (2021-2032)
- 10.2.3 China Immunity Nutraceutical Ingredient Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Immunity Nutraceutical Ingredient Market Size by Type
- 11.1.1 Asia Immunity Nutraceutical Ingredient Revenue by Type (2021-2032)
- 11.1.2 Asia Immunity Nutraceutical Ingredient Sales by Type (2021-2032)
- 11.1.3 Asia Immunity Nutraceutical Ingredient Price by Type (2021-2032)
- 11.2 Asia Immunity Nutraceutical Ingredient Market Size by Application
- 11.2.1 Asia Immunity Nutraceutical Ingredient Revenue by Application (2021-2032)
- 11.2.2 Asia Immunity Nutraceutical Ingredient Sales by Application (2021-2032)
- 11.2.3 Asia Immunity Nutraceutical Ingredient Price by Application (2021-2032)
- 11.3 Asia Immunity Nutraceutical Ingredient Market Size by Country
- 11.3.1 Asia Immunity Nutraceutical Ingredient Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Immunity Nutraceutical Ingredient Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Immunity Nutraceutical Ingredient Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Immunity Nutraceutical Ingredient Market Size by Type
- 12.1.1 SAMEA Immunity Nutraceutical Ingredient Revenue by Type (2021-2032)
- 12.1.2 SAMEA Immunity Nutraceutical Ingredient Sales by Type (2021-2032)
- 12.1.3 SAMEA Immunity Nutraceutical Ingredient Price by Type (2021-2032)
- 12.2 SAMEA Immunity Nutraceutical Ingredient Market Size by Application
- 12.2.1 SAMEA Immunity Nutraceutical Ingredient Revenue by Application (2021-2032)
- 12.2.2 SAMEA Immunity Nutraceutical Ingredient Sales by Application (2021-2032)
- 12.2.3 SAMEA Immunity Nutraceutical Ingredient Price by Application (2021-2032)
- 12.3 SAMEA Immunity Nutraceutical Ingredient Market Size by Country
- 12.3.1 SAMEA Immunity Nutraceutical Ingredient Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Immunity Nutraceutical Ingredient Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Immunity Nutraceutical Ingredient Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Immunity Nutraceutical Ingredient Value Chain Analysis
- 13.1.1 Immunity Nutraceutical Ingredient Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Immunity Nutraceutical Ingredient Production Mode & Process
- 13.2 Immunity Nutraceutical Ingredient Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Immunity Nutraceutical Ingredient Distributors
- 13.2.3 Immunity Nutraceutical Ingredient Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst